Skip to main content

Peer Review reports

From: Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer

Original Submission
13 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
5 Apr 2023 Reviewed Reviewer Report
8 May 2023 Reviewed Reviewer Report
29 May 2023 Author responded Author comments - Zhengjun Qiu
Resubmission - Version 5
29 May 2023 Submitted Manuscript version 5
2 Jun 2023 Author responded Author comments - Zhengjun Qiu
Resubmission - Version 6
2 Jun 2023 Submitted Manuscript version 6
8 Jun 2023 Author responded Author comments - Zhengjun Qiu
Resubmission - Version 7
8 Jun 2023 Submitted Manuscript version 7
25 Jun 2023 Author responded Author comments - Zhengjun Qiu
Resubmission - Version 8
25 Jun 2023 Submitted Manuscript version 8
16 Jul 2023 Reviewed Reviewer Report
22 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
31 Jul 2023 Editorially accepted
23 Aug 2023 Article published 10.1186/s12885-023-11239-w

You can find further information about peer review here.

Back to article page